Aethlon Medical to Release Fiscal First Quarter Financial Results
Aethlon Medical, Inc. (Nasdaq: AEMD), a prominent player in medical therapeutics, is gearing up to announce its financial results for the first quarter of the fiscal year.
Key Financial Results Release Date
The financial results for the quarter ending June 30 will be released at 4:15 p.m. ET on Wednesday, just as Aethlon continues to focus on its mission to address serious health issues, including cancer and life-threatening infectious diseases.
Conference Call Details and Engagement Opportunities
Management will host a conference call shortly after the financial results are made public. This call, scheduled for 4:30 p.m. ET on the same day, aims to delve deeper into the results and any significant corporate developments.
Following the formal presentation, there will be a question and answer segment, allowing stakeholders to engage directly with the management team.
For those wishing to participate, registration for the conference call can be accessed through a specific online portal, with dial-in numbers provided upon registration. For attendees without internet access, a toll-free number will be available for direct calling.
Replay Access Information
Investors interested in revisiting the call can look forward to a replay available approximately one hour post-call, continuing through mid-September. This provides a valuable opportunity for those who could not attend the live event.
The Hemopurifier: An Innovative Approach
One of Aethlon Medical's flagship products, the Hemopurifier, is designed to target and eliminate specific viruses and tumor-derived extracellular vesicles from the bloodstream. Its unique mechanism employs a plant lectin resin to isolate and bind to harmful elements, thereby improving patient outcomes in cancer and infectious disease management.
Clinical Importance and Device Designation
The Hemopurifier has earned a U.S. Food and Drug Administration Breakthrough Device Designation. It signifies its potential in treating patients with advanced cancer who have exhausted standard therapies, as well as addressing viral infections inadequately treated by existing methods.
About Aethlon Medical, Inc.
Headquartered in San Diego, Aethlon Medical, Inc. stands at the forefront of medical device innovation. The organization focuses on technologies that address critical unmet medical needs in oncology and infectious diseases. By harnessing advanced techniques to purify biological fluids, Aethlon offers promising solutions for patients facing severe health challenges.
More details can be found directly on Aethlon Medical's website, where regular updates and information are provided.
Frequently Asked Questions
When will Aethlon Medical release its financial results?
The financial results for the fiscal first quarter will be released at 4:15 p.m. ET on the designated Wednesday.
How can I participate in the conference call?
Participants can register online for the conference call to receive dial-in details. There is also a toll-free number available for those without internet access.
What is the purpose of the conference call?
The conference call is intended to review the financial results and discuss recent developments within Aethlon Medical.
What is the Hemopurifier?
The Hemopurifier is an investigational medical device aimed at removing harmful viruses and cancer-related vesicles from the blood.
How can I access the replay of the conference call?
The replay will be available about one hour after the call ends and can be accessed through the company's website or by designated phone numbers.
